MDDRX
Price
$8.95
Change
+$0.06 (+0.67%)
Updated
Jun 22 closing price
Net Assets
454.07M
RMFEX
Price
$62.71
Change
-$0.10 (-0.16%)
Updated
Jun 22 closing price
Net Assets
116.64B
Interact to see
Advertisement

MDDRX vs RMFEX

MDDRX vs RMFEX Comparison Chart in %
View a ticker or compare two or three
VS
MDDRX vs. RMFEX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDDRX is a Buy and RMFEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 117B vs. MDDRX (454M). RMFEX pays higher dividends than MDDRX: RMFEX (1.45) vs MDDRX (1.26). MDDRX was incepted earlier than RMFEX: MDDRX (12 years) vs RMFEX (24 years). MDDRX (1.05) is less costly to investors than RMFEX (0.62). MDDRX is a more actively managed with annual turnover of: 68.00 vs. RMFEX (30.00). MDDRX has a lower initial minimum investment than RMFEX: MDDRX (0) vs RMFEX (250). RMFEX annual gain was more profitable for investors over the last year : 10.65 vs. MDDRX (-5.07). RMFEX return over 5 years is better than : 38.72 vs. MDDRX (-26.86).
MDDRXRMFEXMDDRX / RMFEX
Total Expense Ratio1.050.62169%
Annual Report Gross Expense Ratio1.050.62169%
Fund Existence12 years24 years-
Gain YTD11.4046.666171%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets454M117B0%
Annual Yield % from dividends1.261.4587%
Returns for 1 year-5.0710.65-48%
Returns for 3 years-12.7636.38-35%
Returns for 5 years-26.8638.72-69%
Returns for 10 years-23.91104.66-23%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CUE30.922.46
+8.64%
Cue Biopharma Inc.
DYN20.891.09
+5.51%
Dyne Therapeutics
AMKR93.553.09
+3.42%
Amkor Technology
APM0.860.03
+3.35%
Aptorum Group Limited
FWRG11.55-0.26
-2.20%
First Watch Restaurant Group